Stay updated on PEMSYS: Pembrolizumab Modulation Clinical Trial
Sign up to get notified when there's something new on the PEMSYS: Pembrolizumab Modulation Clinical Trial page.
Latest updates to the PEMSYS: Pembrolizumab Modulation Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check19 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the study's location.SummaryDifference3%
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedThe website has added new features for user interaction while removing extensive options related to participant groups, interventions, and various data fields for downloads.SummaryDifference4%
- Check41 days agoChange DetectedSeveral key health-related links have been removed, including those related to genetics, melanoma, and rare diseases, which may impact access to important medical information.SummaryDifference0.6%
- Check48 days agoChange DetectedThe website has been updated to version 2.12.2, with numerous new links added related to genetics, melanoma, rare diseases, and clinical trials, enhancing the resource's breadth of information.SummaryDifference5%
- Check55 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.1%
Stay in the know with updates to PEMSYS: Pembrolizumab Modulation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PEMSYS: Pembrolizumab Modulation Clinical Trial page.